首页> 外文期刊>Archives of orthopaedic and trauma surgery >Allograft ligament transplantation in anterior cruciate ligament reconstruction patients with meniscal tears
【24h】

Allograft ligament transplantation in anterior cruciate ligament reconstruction patients with meniscal tears

机译:半月板撕裂前交叉韧带重建患者的同种异体移植物韧带移植

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Background: It currently remains unclear whether the meniscal repair clinical results were affected by the graft used in anterior cruciate ligament (ACL) reconstruction. This retrospective study designed to evaluate the difference in clinical outcomes of meniscal repair using autograft and allograft for the ACL reconstruction. Methods: The injury of the ACL and meniscus was evaluated with MRI and treated simultaneously. One hundred and eighty-nine cases were initially fulfilled the study criteria, and had the surgery in the period June 2007 and July 2010. Thirty-four patients were lost to follow-up. Seventy-five patients underwent meniscus repair with autograft reconstruction of the ACL (autograft group) and 80 patients underwent meniscus repair with allograft reconstruction of the ACL (allograft group). Results: The meniscus healing rate based on the clinical examination of Barrett's criteria was 81.3 (61/75) in the autograft group and 80.0 (64/80) in the allograft (P > 0.05). There was no significant difference in the Lysholm scores in the allograft group compared to the allograft group (89.1 ± 10.6 versus 88.7 ± 11.2, P > 0.05). The values of immunoglobulin's and complements (IgG, IgA, IgM, C3 and C4) were not significantly different between the two groups (P > 0.05). Conclusion: The data support our assumption that patients undergoing meniscal repair associated with ACL reconstruction with allograft had good clinical outcomes. Although allograft implantation induces an immunological response on a subclinical level, there were no signs of allograft affecting the nature of meniscus healing.
机译:背景:目前尚不清楚半月板修复的临床结果是否受到前交叉韧带 (ACL) 重建中使用的移植物的影响。这项回顾性研究旨在评估使用自体移植物和同种异体移植物进行 ACL 重建的半月板修复的临床结果差异。方法:采用MRI评估前交叉韧带和半月板损伤并同步治疗。189例病例最初符合研究标准,并在2007年6月至2010年7月期间接受了手术。34例患者失访。75 例患者接受了半月板修复术和 ACL 自体移植重建术(自体移植组),80 例患者接受了半月板修复术和 ACL 同种异体移植重建术(同种异体移植组)。结果:根据Barrett标准临床检查,自体移植组半月板愈合率为81.3%(61/75),同种异体移植物组为80.0%(64/80)(P>0.05)。同种异体移植组的Lysholm评分与同种异体移植组相比,差异无统计学意义(89.1±10.6 vs 88.7±11.2,P > 0.05)。两组免疫球蛋白和补体(IgG、IgA、IgM、C3和C4)值差异无统计学意义(P>0.05)。结论:数据支持我们的假设,即接受与同种异体移植物前交叉韧带重建相关的半月板修复的患者具有良好的临床结局。尽管同种异体移植物植入在亚临床水平上诱导免疫反应,但没有迹象表明同种异体移植物会影响半月板愈合的性质。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号